文献速递肺栓塞与肺血管病

心脏磁共振成像阈值用于肺动脉高压风险分层

Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial Hypertension.
PubMed 文献 · Am J Respir Crit Care Med · 2020-01-01

该研究基于ASPIRE MRI数据库438例肺动脉高压患者,在发现队列中确定心脏MRI阈值并在测试队列中验证。右心室收缩末期容积指数百分比预测值阈值227%或左心室舒张末期容积指数58 ml/m2可区分1年死亡风险低(<5%)与高(>10%)的患者。右心室射血分数>54%、37-54%和<37%分别对应低、中、高风险。心脏MRI阈值联合REVEAL 2.0或法国注册方法可改善风险分层。

要点

  • 右心室收缩末期容积指数百分比预测值227%可识别1年死亡高风险患者。
  • 右心室射血分数>54%、37-54%、<37%分别对应低、中、高风险。
  • 心脏MRI阈值联合REVEAL 2.0可改善1年死亡风险分层。

核心结论

  • 心脏MRI可采用阈值方法对肺动脉高压患者进行风险分层。
  • 右心室收缩末期容积指数百分比预测值可识别高比例的低风险患者,联合现有风险分层方法可改善风险分层。

研究设计与样本

  • 研究从ASPIRE MRI数据库连续纳入438例肺动脉高压患者,在发现队列中确定阈值并在测试队列中评估。

主要发现

  • 右心室收缩末期容积指数百分比预测值阈值227%或左心室舒张末期容积指数58 ml/m2识别1年死亡风险低(<5%)和高(>10%)的患者,分别将63%和34%的患者识别为低风险。
  • 右心室射血分数>54%、37-54%和<37%分别将21%、43%和36%的患者识别为1年死亡低、中、高风险。
  • 随访心脏MRI时,改善至或维持低风险组的患者1年死亡率<5%。
  • 右心室收缩末期容积指数百分比预测值独立预测结局,与REVEAL 2.0风险评分计算器或改良法国肺动脉高压注册方法联合使用时改善1年死亡风险分层。

关键数值与推荐

  • 右心室收缩末期容积指数百分比预测值阈值227%或左心室舒张末期容积指数58 ml/m2用于区分1年死亡风险低(<5%)与高(>10%)。
  • 右心室射血分数>54%、37-54%、<37%分别对应1年死亡低、中、高风险。

临床怎么用

  • 临床可采用心脏MRI阈值方法对肺动脉高压患者进行风险分层。
  • 右心室收缩末期容积指数百分比预测值可与REVEAL 2.0或改良法国注册方法联合使用以改善风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Pulmonary arterial hypertension (PAH) is a life-shortening condition. The European Society of Cardiology and European Respiratory Society and the REVEAL (North American Registry to Evaluate Early and Long-Term PAH Disease Management) risk score calculator (REVEAL 2.0) identify thresholds to predict 1-year mortality.Objectives: This study evaluates whether cardiac magnetic resonance imaging (MRI) thresholds can be identified and used to aid risk stratification and facilitate decision-making.Methods: Consecutive patients with PAH (n = 438) undergoing cardiac MRI were identified from the ASPIRE (Assessing the Spectrum of Pulmonary Hypertension Identified at a Referral Center) MRI database. Thresholds were identified from a discovery cohort and evaluated in a test cohort.Measurements and Main Results: A percentage-predicted right ventricular end-systolic volume index threshold of 227% or a left ventricular end-diastolic volume index of 58 ml/m2 identified patients at low (<5%) and high (>10%) risk of 1-year mortality. These metrics respectively identified 63% and 34% of patients as low risk. Right ventricular ejection fraction >54%, 37-54%, and <37% identified 21%, 43%, and 36% of patients at low, intermediate, and high risk, respectively, of 1-year mortality. At follow-up cardiac MRI, patients who improved to or were maintained in a low-risk group had a 1-year mortality <5%. Percentage-predicted right ventricular end-systolic volume index independently predicted outcome and, when used in conjunction with the REVEAL 2.0 risk score calculator or a modified French Pulmonary Hypertension Registry approach, improved risk stratification for 1-year mortality.Conclusions: Cardiac MRI can be used to risk stratify patients with PAH using a threshold approach. Percentage-predicted right ventricular end-systolic volume index can identify a high percentage of patients at low-risk of 1-year mortality and, when used in conjunction with current risk stratification approaches, can improve risk stratification. This study supports further evaluation of cardiac MRI in risk stratification in PAH.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Lewis RA, Johns CS, Cogliano M, et al. Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2020. PMID: 31647310. doi:10.1164/rccm.201909-1771OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。